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Abstract Endothelial cells grown on filters developed junctional complexes that reduced diffusional transport and inCTeased electrical resistance over the cell layer. Induction of tissue factor by recombinant interleukin-1/3 led to a highly polarized tissue factor expression on the apical cell surface only. After prolonged growth to allow deposition of matrix, removal of the endothelial cells by collagenase or by 0.1 mol/L NH4OH left behind some cellular material as well as tissue factor, which was only detectable in the upper compartment. A human bladder carcinoma cell line, which does not form tight junctions and expresses tissue factor constitutively, showed essentially no polarity. Endothelial cell secretory compounds T he most potent trigger of blood clotting known today, tissue factor (TF), is constitutively synthesized in several tissues. 1 Some cell types (monocytes and endothelial cells [ECs] ) require an inducing stimulus to express the TF gene; TF activity is inducible in these cells by a large number of different compounds. 24 A variable fraction of this newly synthesized TF becomes available on the surface of intact cells as a glycosylated integral membrane protein of 263 amino acid residues with a transmembrane part of 23 and a C-terminal cytoplasmic tail of 21 residues.
Given that ECs have a luminal side facing the blood and an abluminal side facing the underlying part of the vascular wall and have been shown to be polarized, 5 ' 6 the polarity of TF expression is of interest. We report here that in human umbilical vein ECs (HUVECs) cultured under in vitro conditions, where they form junctional complexes or tight junctions, TF expression is almost entirely directed toward the apical (luminal) surface of the cell, whereas plasminogen activator inhibitor-1 (PAI-1), tissue-type plasminogen activator (TPA), and von Willebrand factor (vWf) show different patterns of secretion.
Methods

Materials
Collagenase type 1, bovine serum albumin (BSA), purified human factor X (FX) (free of FXa), saponin, and toluidine red were obtained from Sigma; trypsin-EDTA, RPM1 1640 (low endotoxin), L-glutamine, and penicillin-streptomycin from Flow or Whittaker; fetal calf serum (FCS) from GIBCO; like von Willebrand factor, tissue plasminogen activator, and plasminogen activator inhibitor-1 were constitutively released to both sides. The added secretion due to recombinant interleukin-10 stimulation of the endothelial cells observed for von Willebrand factor and tissue plasminogen activator was, however, localized to the apical surface. The availability of tissue factor on the luminal surface of endothelial cells, ie, allowing contact with factor VII in the flowing blood, has potentially very significant pathophysiological consequences. 
Isolation and Culturing of HUVECs
ECs were prepared from human umbilical veins essentially according to the procedure of Jaffe et al. 7 The cells were cultured at 37°C in 5% CO 2 in 25-cm 2 bottles (Costar) using RPMI 1640 supplemented with 20% native FCS, L-glutamine (380 Mg/mL), penicillin (100 U/mL), and streptomycin (100 /ig/mL). Confluent primary and secondary cultures were propagated at a split ratio of 1:3 with addition of EC growth supplement (10 /ig/mL) and heparin (90 /ig/mL) to the growth medium. To control homogeneity of the cultures, experiments using fluorescein-labeled antibodies to vWf were performed. In all polarity experiments tertiary cultures were used. After the final splitting the cells were plated at 2x10* cells/filter and grown for 10 days on uncoated polycarbonate Transwell membranes (Costar; pore size, 0.4 fim) and supplied with 1.5 mL growth medium in the upper compartment and 2.6 mL in the lower compartment.
Cell death was monitored by using trypan blue exclusion and release of lactate dehydrogenase."
J82 Cells
The human bladder carcinoma cell line J82 was obtained from ATCC and cultured in minimum essential medium (GIBCO) supplied with 10% FCS. For experiments approximately 2x10* cells were plated in Transwell clusters.
Measurement of TF Activity
The method was based on the activation of FX by the TF-FVII-Ca 2+ membrane complex. The reaction between FXa and its peptide substrate was monitored by the increase in OD 405 nm over 60 minutes.
The cells were washed carefully three times and were incubated with Tris buffer (0.05 mol/L Tris and 0.1 mol/L Nad, pH 7.5) containing BSA (5 mg/mL) and 4 mmol/L Cad 2 . The compartments to be tested for TF expression were supplied with FVTIa (10 U/mL) and FX (0.1 U/mL). The culture trays were placed in an incubator (New Brunswick) at 37°C and shaken at 100 rpm. At 10, 20, and 40 minutes samples of 30 fiL were taken from each compartment and added to a microtiter plate (Nunc) containing 240 fiL Tris buffer (pH 7.4), with 10 mmol/L EDTA in each well to stop the reaction, and mixed thoroughly. After this, 30 /xL of substrate FXa-1 (each vial was reconstituted in 2.5 mL sterile water) was added to each sample. The OD was read at 405 nm in a Titertek Multiskan at 0 and 60 minutes and the change in OD 405 was calculated. The cells were stained with toluidine red at the end of the experiment to monitor the integrity of the confluent layer.
Electron Microscopy
Cells on polycarbonate filters were processed for electron microscopy as described by Parton et al.
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Assay of vWf vWf was measured in a sandwich enzyme-linked immunosorbent assay system by using goat anti-human vWf (Atlantic) as the catching antibody and rabbit anti-human vWf (DAKO) for detection. The catching antibody was diluted 1:500 with phosphate-buffered saline (PBS), and 100 ^iL/well was incubated overnight at 4°C, followed by coating for 1 hour at 37°C with 150 /iL/well 3% skimmed milk in 0.1% Tween in PBS (PBS-T). Growth medium (100 jiL) containing the released antigen was added and incubated for 3 hours at 37°C. The second antibody was a 1:10 000 dilution of rabbit anti-human vWf (DAKO); 100 /iL/well was incubated for 3 hours at 37°C. Swine anti-rabbit immunoglobulin conjugated with alkaline phosphatase (DAKO) was diluted 1:1000 with PBS-T, and 100 /ilVwell was incubated for 2.5 hours at 37°C. Between incubations the wells were washed four times with PBS-T. Substrate p-nitrophenyl phosphate (Sigma) was added and incubated for 30 minutes at 37°C before OD 405 nm was measured. Control wells gave no background. Dilutions of normal human serum were used as standards.
Other Methods
TPA and PAI-1 were measured by using Biopool kits as described by the manufacturer. Electrical resistance over the Transwell membrane was measured by using the Millicell-ERS voltohmmeter (Millipore). Protein was measured by a modified Lowry procedure.
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Results ECs
Previous studies have demonstrated that TF induction in HUVECs is unimpaired for up to at least 10 passages and for at least 3 weeks in confluent cultures when the cells are grown in the presence of EC growth supplement and heparin. 12 The studies presented here were, if not otherwise stated, performed using passage-three cells on day 10 (3 to 5 days after having reached confluency). No increase in lactate dehydrogenase release or trypan blue uptake was observed during the experiments.
To study the polarity of expression of specific genes in ECs, it is necessary to establish conditions under which there are well-defined boundaries between different Second, we measured the increase in electrical resistance across the cell layer. The increase of electrical resistance was regularly 90 to 130 fl cm 2 when the cultures were followed from seeding to beyond confluency. This finding agrees with previous data.
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Third, we monitored the appearance of tight junctions by electron microscopy, in which structures suggesting the presence of junctional complexes were seen at or near the luminal end of cell borders (Fig 2A and  2B) . These electron microscopical observations further substantiated that tight junctions or related junctional complexes were present. Electron micrographs of J82 cells showed no similar structures (Fig 2C) Synthesis of TF TF synthesis was induced by adding rIL-1/3 (final concentration, 50 U/mL) to either Transwell compartment. After 6 hours significant TF activity was expressed on the upper (luminal) surface (Fig 3) . This inducible activity increase involves de novo RNA and protein synthesis. - 15 The activity detectable on the lower (abluminal) surface was in most cases not significantly above background (uninduced cells). The TF activity measured on the apical surface was only about 20% of the total cellular activity, as revealed when cells in parallel wells were opened with 0.02% saponin.
rIL-1/3 was an equally good inducer of TF expression on the luminal surface when supplied to the cells from the abluminal (basolateral) surface. Very low or essentially no TF activity above background was detected on the abluminal side irrespective of whether rIL-)3 was given to the upper, lower, or both compartments. Significant TF activity was always only observed on the luminal surface.
These experiments demonstrated that IL-1/3 receptors are at least equally available to ligand binding on both sides of the cell. Control experiments performed to study the specificity of the detection assay included removal of FVIIa from the detection system, which resulted in no detectable activation of FX (data not shown). Incubation with a neutralizing monoclonal antibody to TF prior to the activation assay abolished any FX activation when a final antibody concentration of 0.2 Atmol/L was used. The activation of FX was thus clearly dependent on the extrinsic coagulation pathway (ie, TF and FVII). For control experiments we also used the human cell line J82, which, as a cancer cell line, is not expected to give tight junctions. In electron microscopy no junctional complexes or tight junctions were seen (Fig 2C) . J82 is a well-documented constitutive TF producer 16 and had a sizable part (about one third) of its total surface TF activity available to FVII and FX in the lower compartment (Fig 4) . For both HUVECs and J82, control experiments revealed no diffusion of FXa from the upper to the lower compartment during the period (40 to 60 minutes) of the actual assay. To further establish that there were no barriers prohibiting exchange between the basolateral cell surface and the medium in the lower compartment, we also looked at the distribution of three secretory products from HUVECs: TPA, PAI-1, and vWf. None of these are secreted with such a specific polarity pattern as TF expression (Fig 5) . Their responsiveness to rIL-10 differed. There was no apparent hindrance to the free mobility of these factors underneath the cells, thus allowing their simultaneous appearance in upper and lower compartments. In addition to the constitutive EC release of vWf, rIL-1/3 stimulation gave an induced release, which took place mainly from the apical surface of the ECs. Release of TPA behaved similarly. PAI-1, which showed no significant response to rIL-1/3 stimulation, was constirutivery secreted about equally to both compartments during 6 to 12 hours, confirming the results of Schleef et al.
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TF in EC Matrix
ECs were removed from their supporting surface by treatment with collagenase (0.2% wt/vol at 37°C for 5 to 7 minutes) or 0.1 mol/L NH»OH for 2 minutes. Prior to confluency no TF was detected after removal of the cells. After 10 days, however, significant activity was observed (Fig 6) . Toluidine red staining of the Transwell membranes after collagenase or NH4OH treatment suggested the presence of membrane fragments.
Discussion
Our results confirm our observation 12 that only about 20% of the total TF activity induced by rIL-1/3 in HUVEC monolayers is available on the cell surface. We show here that TF expression in HUVECs grown under specified conditions occurs in a polar manner. By using the generation of activated FX to measure TF activity, we found only traces of TF activity on the basolateral side compared with the TF activity observed on the apical side of the cell layer. The same distribution of TF was observed whether rIL-10 was added to the lower, the upper, or to both compartments. Since diffusion of IL-1/3 through the cell layer can be excluded, this reveals that IL-1/3 receptors exist on both sides of the cellular monolayer and that the polycarbonate membrane filter and the subendothelial matrix deposited on its surface do not prevent the access of this ligand to its receptor. The release of TPA and PAI-1 and especially of the high-molecular-weight vWf to the medium in contact with the basolateral surface indicated that there was no block to diffusion on this side of the cell layer even for very large proteins. The human bladder carcinoma cell line J82 does not form tight junctions and expresses TF constitutively. One would therefore expect TF to be available on either side of this cell layer, which indeed was the case, again demonstrating that there was no steric or other hindrance prohibiting contact between TF and FVIIa or FX on the abluminal surface. The J82 surface areas primarily available for interaction with FVII from either side are not known and may well correspond to the 2:1 ratio observed for the TF activity. One apparent prerequisite for polar expression of any gene is the presence of structures defining different cell surface areas and preventing lateral diffusion of proteins in the cell membrane. Tight junctional complexes as described in intestinal and kidney epithelium constitute the best example of such structures. Three criteria are usually applied to evaluate the existence of junctional complexes: loss of permeability and increase of electrical resistance across the cell layer combined with morphological and immunocytochemical observations. Neither loss of permeability nor moderately increased electrical resistance is sufficient to allow conclusions about tight junctions. When all three criteria are present, however, a situation with tight junctions or junctional complexes may be assumed.
ECs are known to have a less tight seal between them, which accords with the modest increase in electrical resistance. 1314 In addition, the existence of the transcytotic pathway in ECs may contribute to both these sets of data by lowering the electrical resistance and may also increase the inulin transport. One obvious caveat in interpreting these results is caused by the fact that we sampled the medium to measure FXa generation as an indicator of TF availability. If a major part of FXa remains bound to the cell membrane or the subcellular matrix after activation, the difference in available FXa in the medium of either compartment might be secondary to the distribution of FX-binding structures. We conclude that the most likely interpretation of our observations is that under the growth conditions specified here, HUVECs form junctional complexes and demonstrate a marked polarity of TF expression after rIL-1/J stimulation. Surface-available TF is almost entirely inserted into the apical cell membrane. Polarity of expression has been demonstrated for several other gene products in ECs. 5 '* 18 This suggests the presence of regulatory mechanisms, including TF transport. Deletion and point mutation experiments are being performed to understand the nature of the apical surface label "tag" present in the TF molecule. The presence of active TF on the luminal side of endothelial cells also in vivo may have important pathophysiological consequences, if no tissue factor pathway inhibitor (TFPI) suppresses the TF effect. The role of TFPI in preventing initiation of coagulation by exposed TF will be investigated in suitable transgenic animal models.
Entirely opposite results suggesting TF localization solely on the abluminal surface have been reported 19 for ECs grown under conditions that did not allow the formation of tight junctions, as the cells were examined within 24 hours after achieving confluence.
TF is expressed in epithelial cells and may be useful as a marker for transport to their apical surface if the polarity seen here is a universal phenomenon in polarized cells. The appearance of TF activity in the matrix remains unexplained. Whereas the basolateral TF activity present in J82 cells or in nonconfluent ECs was easily detectable in the lower compartment, this was not the case with the matrix-bound TF activity. The latter can only be detected in the upper compartment after removal of the ECs. The activity is of comparable magnitude to that revealed inside the cells when opened with saponin. The simplest explanation for these findings would be that NH4OH or collagenase treatment both leave behind pieces of cell membrane attached to the matrix and that internal membraneous structures containing TF remain attached to these pieces of plasma membrane via, eg, cytoskeletal elements. This would explain why this TF activity is only available from the upper compartment.
